CHU Grenoble
Grenoble, France
NCT Number: NCT03776773
It has been demonstrated that allergic rhinitis (AR) reduces sleep quality by some components such as nasal obstruction. Pollution and allergen exposure worsening AR, sleep quality is deteriorated.
Sleep is associated to physical and mental health, alterations in sleep could explain the link between AR and work productivity diminution, impairment in daily activities or emotional problems.
However, interactions between air pollution, sleep and allergic diseases are insufficiently understood.
The main objective of this study is to determine the impact of pollution and pollens on sleep parameters.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Grenoble, France
Over 150 million people have allergic rhinitis (AR) in Europe and around 30% have uncontrolled AR during allergen exposure. It has been demonstrated that AR reduces sleep quality by some components such as nasal obstruction. Pollution and allergen exposure worsening AR, sleep quality is deteriorated.
Sleep is associated to physical and mental health, alterations in sleep could explain the link between AR and work productivity diminution, impairment in daily activities or emotional problems.
However, interactions between air pollution, sleep and allergic diseases are insufficiently understood.
Moreover, the prevalence of OSA in patients with AR is higher than in subjects without AR. Nasal obstruction could explain the increased risk of OSA.
This prospective, open study will compare sleep quality in 2 different groups: AR patients and patients without AR during the pollen season and outside the pollen season.The main objective is to determine the impact of pollution and pollens on sleep parameters for subjects with AR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pollution exposure and sleep data will be recorded by pollution sensor and polysomnography respectively. In order to compare the variations according to the pollinisation season and the allergic rhinitis status of the patients.
Time frame: 6 days
Change in AHI according to the level of pollution particle matters and volatile organic compounds (VOCs)
Time frame: 6 days
Change in Pittsburgh score according to the level of pollution particle matters and volatile organic compounds (VOCs)
Time frame: 6 days
Change in EQ-5D score according to the level of pollution particle matters and volatile organic compounds (VOCs)
Time frame: 6 days
Change in number of medications (antiallergics and hypnotics) according to the level of pollution particle matters and volatile organic compounds (VOCs)
University Hospital, Grenoble
Other
Acronym: POLLAR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03919955
Apnea, Dyssomnias
Boston, Massachusetts, United States
View Trial DetailsNCT06050720
Apnea, Dyssomnias
Stoke-on-Trent, United Kingdom
View Trial DetailsNCT04875364
Apnea, Dyssomnias
La Jolla, California, United States
View Trial DetailsNCT05197855
Apnea, Dyssomnias
Grenoble, France
View Trial Details